Chinese english Germany Japanese Korea

2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether

2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether Struktur
929808-72-0
CAS-Nr.
929808-72-0
Englisch Name:
2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether
Synonyma:
3-[(2,4-dichlorophenoxy)methyl]-6-(pyridin-3-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole;1,2,4-Triazolo[3,4-b][1,3,4]thiadiazole, 3-[(2,4-dichlorophenoxy)methyl]-6-(3-pyridinyl)-;2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether
CBNumber:
CB91989521
Summenformel:
C15H9Cl2N5OS
Molgewicht:
378.24
MOL-Datei:
929808-72-0.mol
Request For Quotation

2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether Eigenschaften

Dichte
1?+-.0.1 g/cm3(Predicted)
pka
2.50±0.12(Predicted)

Sicherheit

2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether Chemische Eigenschaften,Einsatz,Produktion Methoden

2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
VITAS-M LABORATORY, LTD. --
 Russia 6754 64
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
Specs --
 info@specs.net The Netherlands 6835 70
  • 2,4-dichlorophenyl [6-(3-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl]methyl ether
  • 3-[(2,4-dichlorophenoxy)methyl]-6-(pyridin-3-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
  • 1,2,4-Triazolo[3,4-b][1,3,4]thiadiazole, 3-[(2,4-dichlorophenoxy)methyl]-6-(3-pyridinyl)-
  • 929808-72-0
Copyright 2019 © ChemicalBook. All rights reserved